Cardiovascular Diseases Clinical Trial
To continue a study of premature coronary heart disease mortality among men and women aged 35-54 in Allegheny County, Pennsylvania.
BACKGROUND:
The decline in coronary heart disease mortality apparently began around 1963 in the United
States and increased in intensity in later years. In the 35-44 age groups the decline began
somewhat later, perhaps around 1968. The decline has been found in all four race sex groups
and in all age groups including the very old. This decline has also been noted in many other
countries besides the United States. The decline of coronary heart disease mortality could
obviously be a function of either a change in incidence or in case fatality or both. During
the time of this decline in coronary heart disease mortality a great many changes were
occurring both in the care of the cardiac patients and changes in risk factors. The fact
that the decline occurred across all age as well as race, and sex groups as well as in many
other countries suggested that one single factor may not have accounted for the decline.
It was very unlikely that the decline of sudden death was due to improved out-of-hospital
care or an early recognition of symptoms. The three percent per year decline suggested that
acute precipitating factors other than the underlying atherosclerosis were the most likely
factors to account for the decline, especially in the younger age groups of men.
The study was designed to evaluate whether the decrease in coronary heart disease mortality
was real or due to an artifact of certification practices or accuracy of diagnosis. The
design was based on the fact that the best opportunity to study the decline was in the 35-44
age group.
DESIGN NARRATIVE:
A retrospective review was made of all death certificates certified to coronary heart
disease, all other cardiovascular deaths, and all non-traumatic but possibly sudden deaths
certified by the coroner. The review included autopsy records, coroner's reports, hospital
records, information from certifying physicians, and interviews with next-of-kin or
witnesses. A determination was made of the contribution to the decline of out-of-hospital
sudden death and prior history of heart disease, other diseases, and possibly cigarette
smoking. The changing mode of death for in-hospital deaths was also evaluated.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|